Anticonvulsant Medications Extend Worm Life-Span
- 14 January 2005
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 307 (5707) , 258-262
- https://doi.org/10.1126/science.1105299
Abstract
Genetic studies have elucidated mechanisms that regulate aging, but there has been little progress in identifying drugs that delay aging. Here, we report that ethosuximide, trimethadione, and 3,3-diethyl-2-pyrrolidinone increase mean and maximum life-span of Caenorhabditis elegans and delay age-related declines of physiological processes, indicating that these compounds retard the aging process. These compounds, two of which are approved for human use, are anticonvulsants that modulate neural activity. These compounds also regulated neuromuscular activity in nematodes. These findings suggest that the life-span–extending activity of these compounds is related to the anticonvulsant activity and implicate neural activity in the regulation of aging.Keywords
This publication has 17 references indexed in Scilit:
- Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegansProceedings of the National Academy of Sciences, 2004
- eat-2 and eat-18 Are Required for Nicotinic Neurotransmission in the Caenorhabditis elegans PharynxGenetics, 2004
- Long-Lived C. elegans daf-2 Mutants Are Resistant to Bacterial PathogensScience, 2003
- Interpreting interactions between treatments that slow agingAging Cell, 2002
- Block of Cloned Human T-Type Calcium Channels by Succinimide Antiepileptic DrugsMolecular Pharmacology, 2001
- Genetic pathways that regulate ageing in model organismsNature, 2000
- A genetic selection for Caenorhabditis elegans synaptic transmission mutants.Proceedings of the National Academy of Sciences, 1996
- 3,3-Dialkyl- and 3-Alkyl-3-Benzyl-Substituted 2-Pyrrolidinones: A New Class of Anticonvulsant AgentsJournal of Medicinal Chemistry, 1996
- A C. elegans mutant that lives twice as long as wild typeNature, 1993
- Characterization of ethosuximide reduction of low‐threshold calcium current in thalamic neuronsAnnals of Neurology, 1989